Tcg Crossover Management
$3.5B Assets Reported
54 Holdings
Latest filing 2026-03-31
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | 6,481,085 | $722M | 20.6% |
| CGON | CG ONCOLOGY INC | 3,670,206 | $248M | 7.1% |
| TNGX | TANGO THERAPEUTICS INC | 10,531,071 | $220M | 6.3% |
| COGT | COGENT BIOSCIENCES INC | 4,946,894 | $190M | 5.4% |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 4,286,480 | $170M | 4.9% |
| DNTH | DIANTHUS THERAPEUTICS INC | 1,676,624 | $141M | 4.0% |
| TYRA | TYRA BIOSCIENCES INC | 3,248,980 | $124M | 3.6% |
| IMVT | IMMUNOVANT INC | 4,457,988 | $111M | 3.2% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 11,020,968 | $105M | 3.0% |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,062,049 | $98M | 2.8% |
Track Tcg Crossover Management's 13F portfolio: $3.5B in reported holdings, 54 positions. Top holdings, AUM, and quarterly changes on SentiSense.